We are live on
!
Find out more
HighTower Advisors Portfolio holdings
AUM
$94.2B
1-Year Est. Return
21.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$64.7B
AUM Growth
+$2.95B
(+4.8%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.8%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
3,995
New
390
Increased
1,526
Reduced
1,536
Closed
329
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$463M |
| 2 |
ExxonMobil
XOM
|
+$326M |
| 3 |
RTX Corp
RTX
|
+$222M |
| 4 |
Target
TGT
|
+$108M |
| 5 |
Whirlpool
WHR
|
+$96.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$308M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$125M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$54.3M |
| 4 |
Apple
AAPL
|
+$44.3M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$40.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.26% |
| 2 | Financials | 9.5% |
| 3 | Healthcare | 6.23% |
| 4 | Consumer Discretionary | 6.19% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
XPeng
XPEV
$12.2B
| $83K | ﹤0.01% |
11,612
+209
| +2% | +$1.65K |
|
|
NVRO
3227
DELISTED
NEVRO CORP.
NVRO
| $83K | ﹤0.01% |
+10,006
| New | +$107K |
|
|
SILV
3228
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $83K | ﹤0.01% |
10,198
-5,770
| -36% | -$47.1K |
|
3229
Amneal Pharmaceuticals
AMRX
$5.75B
| $82K | ﹤0.01% |
+13,203
| New | +$83.8K |
|
3230
CALL
Occidental Petroleum
OXY
$55.5B
| $81K | ﹤0.01% |
40,000
+39,900
| +39,900% | +$2.56M |
|
|
AMRN
3231
Amarin Corp
AMRN
$286M
| $81K | ﹤0.01% |
6,070
+935
| +18% | +$16.1K |
|
3232
Holley
HLLY
$324M
| $81K | ﹤0.01% |
22,630
+3,078
| +16% | +$12K |
|
3233
Genius Sports
GENI
$1.94B
| $80K | ﹤0.01% |
14,697
+50
| +0.3% | +$267 |
|
3234
OmniAb
OABI
$304M
| $80K | ﹤0.01% |
21,382
| – | – |
|
|
GRFS
3235
Grifois
GRFS
$5.3B
| $79K | ﹤0.01% |
+12,384
| New | +$86.1K |
|
|
SYRS
3236
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $79K | ﹤0.01% |
15,348
+431
| +3% | +$2.27K |
|
|
CDMO
3237
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $79K | ﹤0.01% |
11,241
| – | – |
|
|
3238
CALL
Apple
AAPL
$4.98T
| $77.8K | ﹤0.01% |
31,200
+31,000
| +15,500% | +$5.78M |
|
3239
Upexi
UPXI
$60.1M
| $77K | ﹤0.01% |
10,711
| – | – |
|
3240
AtlasClear
ATCH
$25.9M
| $77K | ﹤0.01% |
1,241
+1,040
| +517% | +$71.8K |
|
|
MAV
3241
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
| $76K | ﹤0.01% |
11,115
-1,246
| -10% | -$9.98K |
|
|
MTA
3242
Metalla Royalty & Streaming
MTA
$723M
| $74K | ﹤0.01% |
26,608
+1,483
| +6% | +$4.55K |
|
3243
Coeur Mining
CDE
$15.7B
| $73K | ﹤0.01% |
13,205
-300
| -2% | -$1.55K |
|
|
CMPS
3244
Compass Pathways
CMPS
$1.53B
| $73K | ﹤0.01% |
12,132
+1,781
| +17% | +$14K |
|
3245
Archer Aviation
ACHR
$3.72B
| $72K | ﹤0.01% |
20,398
+3,575
| +21% | +$13.3K |
|
3246
Allogene Therapeutics
ALLO
$621M
| $72K | ﹤0.01% |
30,556
| – | – |
|
3247
Editas Medicine
EDIT
$413M
| $72K | ﹤0.01% |
16,228
+810
| +5% | +$4.57K |
|
3248
Bioventus
BVS
$821M
| $71K | ﹤0.01% |
+12,237
| New | +$67.1K |
|
|
HIO
3249
Western Asset High Income Opportunity Fund
HIO
$335M
| $71K | ﹤0.01% |
18,950
+3,342
| +21% | +$12.7K |
|
|
OXLC
3250
Oxford Lane Capital
OXLC
$823M
| $71K | ﹤0.01% |
2,641
-2
| -0.1% | -$53 |
|
Similar funds
HighTower Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, HighTower Advisors held 3,995 positions worth $64.7B, up 4.8% from $61.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
HighTower Advisors deployed $2.46B of net new capital in Q2 2024, opening 390 new positions and adding to 1,526 existing holdings. Its largest new stake was Invesco QQQ Trust: 1,029,639 shares worth $493M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $125M trimmed.
- HighTower Advisors's largest Q2 2024 buy was Invesco QQQ Trust: 1,029,639 shares worth $493M.
- HighTower Advisors added most to ExxonMobil in Q2 2024, an estimated $326M increase.
- HighTower Advisors's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $125M.
- HighTower Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $308M.
- HighTower Advisors's ten largest holdings make up 19% of its $64.7B portfolio in Q2 2024.
- HighTower Advisors opened 390 new positions and closed 329 in Q2 2024.
- HighTower Advisors's portfolio value rose 4.8% quarter-over-quarter to $64.7B.
Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.